The Syndromic versus Laboratory Diagnosis of Sexually Transmitted Infections in Resource-Limited Settings by Ghebremichael, Musie
 The Syndromic versus Laboratory Diagnosis of Sexually
Transmitted Infections in Resource-Limited Settings
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Ghebremichael, Musie. 2014. “The Syndromic versus Laboratory
Diagnosis of Sexually Transmitted Infections in Resource-
Limited Settings.” ISRN AIDS 2014 (1): 103452.
doi:10.1155/2014/103452.
http://dx.doi.org/10.1155/2014/103452.
Published Version doi:10.1155/2014/103452
Accessed February 19, 2015 4:01:19 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12153011
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Research Article
The Syndromic versus Laboratory Diagnosis of Sexually
Transmitted Infections in Resource-Limited Settings
Musie Ghebremichael
Harvard Medical School and Ragon Institute of MGH, MIT and Harvard, 400 Technology Square,
Room 857, Cambridge, MA 02129, USA
Correspondence should be addressed to Musie Ghebremichael; musie ghebremichael@dfci.harvard.edu
Received 12 November 2013; Accepted 20 January 2014; Published 5 March 2014
Academic Editors: K. Arasteh, G. D’ettorre, and A. Guihot-Thevenin
Copyright © 2014 Musie Ghebremichael. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Sexually transmitted infections (STIs) are highly prevalent in sub-Saharan Africa, where there is a severe HIV epidemic. Thus,
accurate recognition and diagnosis of STIs are essential for successful HIV prevention programs in the region. Due to lack of
trained personnel and adequate laboratory infrastructure in the region, information regarding the profile of STIs relies essentially
on self-reported or physician-diagnosed symptoms.Themain objective of the study was to assess the effectiveness of the syndromic
diagnosis of STIs, which is often used as a proxy for laboratory diagnosis of STIs in sub-Saharan Africa and other resource-
limited settings.The study builds on previously collected data from a community-based survey in Northern Tanzania.We found no
significant agreements between patient-reported STIs symptoms and laboratory-confirmed STIs tests.The reported STIs symptoms
had high specificity (range = 85–99%) and poor sensitivity (range = 2–17%). Knowledge gained from our study will have significant
public health implications, and can help improve the syndromic diagnosis of STIs.
1. Introduction
AIDS is a major public health challenge in sub-Saharan
Africa, and the prevalence of other STIs in the region is high
[1, 2]. An estimated 22.9 million people infected with HIV
live in sub-Saharan Africa, and approximately 1.2 million
deaths from AIDS occurred in sub-Saharan Africa [3]. There
is compelling evidence that STIs affect the transmission of
HIV. STIs facilitate the sexual acquisition and transmission of
HIV infection and HIV infection increases the risk of other
STIs [4, 5]. Hence, the recognition, treatment, and prevention
of STIs to reduce the risk of HIV transmission should be a
public health priority, especially in sub-Saharan Africa where
antiretroviral therapymay not be readily available.More than
two-thirds of patients living with HIV in sub-Saharan Africa
have no access to antiretroviral therapy [6].
STIs can be diagnosed in a number of different ways,
including laboratory and syndromic diagnosis. Laboratory
diagnosis is the most accurate method of making a diag-
nosis. However, it is expensive and is not feasible in many
settings as it requires sophisticated laboratory facilities and
qualified personnel who can perform technically demanding
procedures. Moreover, laboratory diagnosis of STIs is time-
consuming and results often cannot be made available at the
same visit, thereby causing a delay in treatment initiation.
For these reasons, the syndromic diagnosis of STIs remains
the only feasible option in some resource-limited settings.
Syndromic diagnosis of STIs is based on the identification of
a group of symptoms and signs that characterize a clinical
condition [7, 8]. It is simple, cost effective, and capable of
yielding rapid diagnosis for immediate treatment. Moreover,
this technique can be implemented at all levels of the health
care system. Despite these advantages, it has several limi-
tations: syndromic diagnosis relies on subjective judgment,
cannot detect asymptomatic infections, and may result in
overdiagnosis/overtreatment and potential drug resistance
[9–11].
Due to a lack of trained personnel and adequate lab-
oratory infrastructure in sub-Saharan Africa, information
regarding the profile of STIs relies essentially on self-reported
or physician-diagnosed STIs. However, there is still no
consensus on its performance and several studies from the
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region have reported inconsistent results. The mixed reports
might be due to the fact that the studies were carried out in
particular groups that are not representative of the overall
population, such as STD or antenatal clinic attendees [12–
14]. Therefore, there is a public health need to evaluate the
validity of the syndromic diagnosis of STIs using population-
based studies from the region, that is, the urgent need for a
comparative study of syndromic and laboratory diagnosis of
STIs in sub-Saharan Africa. The main objective of the study
was to evaluate the performance of syndromic diagnosis of
STIs in comparison with laboratory-confirmed STIs.
2. Materials and Methods
2.1. Study Design and Study Sample. The study participants
consisted of 2,019womenwhowere enrolled in a community-
based survey, which was conducted from November 2002 to
March 2003 in the Moshi Urban District of the Kilimanjaro
Region.The Kilimanjaro Region, located in Northern Tanza-
nia adjacent to the Kenyan border, is one of Mainland Tan-
zania’s 20 regions and is experiencing a mature generalized
stage of the HIV epidemic. Tanzania, with a population of
34.5million, has about 7% of its adults infectedwithHIV [15].
In theMoshi District of Northern Tanzania, the prevalence of
HIV infection is about twice that of the national average.
Study participants were selected to participate in the
survey based on a two-stage sampling design. During the first
stage of sampling, a total of 150 clusters were selected from
the Moshi Urban District. In the second stage of sampling, a
number of households were randomly selected from each of
the 150 clusters and 2,019 women who were residents of the
households were enrolled. A detailed description of the study
protocol, data gathering instruments, and procedures and
laboratory methods has been previously published [16, 17].
2.2. Study Variables. Demographic and socioeconomic char-
acteristics including age, education, ethnicity, religion, and
occupation were obtained. High-risk behaviors including
alcohol abuse, age at first sex, number of sexual partners, and
frequency of condom use were obtained. Symptoms of STIs
including abdominal pain, abnormal genital discharge, foul
smell in the genital area, excessive genital secretions, swelling
of lymphnodes in the genital area, itching in the genital
area, burning pain on micturation, pain during intercourse,
and genital ulcers were obtained. Blood and urine samples
were obtained from 1,418 and 1,440 women, respectively,
who agreed to further testing for STIs. The blood samples
were tested for HIV-1, HSV-2, and active and past syphilis.
The urine samples were tested for chlamydia, gonorrhea,
Trichomonas, andMycoplasma genitalium.
2.3. Statistical Analysis. Descriptive measures (such as mean,
median, standard deviation, interquartile range, frequencies,
and percentages) were used to summarize the data. Sensi-
tivity and specificity together with their corresponding 95%
confidence intervals were calculated to assess the predictive
accuracy of each STIs symptom. Exact binomial confidence
intervals were used to estimate confidence intervals for rates
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Figure 1: Prevalence of self-reported STIs symptoms and laboratory
confirmed STIs (SSTD1: abdominal pain, SSTD2: abnormal genital
discharge, SSTD3: foul smell in the genital area, SSTD4: excessive
genital secretions, SSTD5: swelling of lymphnodes in the genital
area, SSTD6: itching in the genital area, SSTD7: burning pain on
micturation, SSTD8: pain during intercourse, and SSTD9: genital
ulcers).
of STIs, sensitivities, and specificities. Kendall’s tau-𝑏 was
used to measure agreements between patient-reported STIs
symptoms and laboratory confirmed STIs. The reported
numbers of STIs symptoms were summed to obtain the total
number of STIs symptoms for each participant. Receiver
operating characteristic (ROC) curve was then constructed
using sensitivity and specificity obtained from every pos-
sible symptom threshold. The area under the ROC curve
(AUROC) was used to evaluate the overall diagnostic accu-
racy of the syndromic diagnosis of STIs. Bootstrap-based
confidence intervals were calculated for the AUROC.
3. Results
We restricted our analysis towomenwhowere tested for STIs;
a total of 1,520 women were tested for STIs. The median age
was 28 years (IQR = 23–35), and median age at first sex was
19 years (IQR = 17–21).Themajority of study participants had
pre-secondary education (77%), had not used a condom in
the prior 12 months (77%), had one sex partner in the last
three years (84%), and had a husband/partner (61%). Fifty
percent of the women tested positive for at least one STI.
Figure 1 displays the rates of STIs symptoms and tests
among the women included in the analysis. The prevalence
rates of HSV-2, HIV-1, and Trichomonas were 43%, 11%,
and 11%, respectively. The prevalence rates of the other STIs
were below 5.0%. Among the tested women, 30% reported at
least one STIs symptom. The most prevalent STIs symptom
was lower abdominal pain (16%), followed by itching in the
genital area (15%), pain during intercourse (9.4%), abnormal
genital discharge (6.3%), burning or pain on micturation
(6%), excessive genital secretions (4.1%), foul smell in genital
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Figure 2: Prevalence of self-reported STIs symptoms amongwomen
tested positive for STIs (SSTD1: abdominal pain, SSTD2: abnormal
genital discharge, SSTD3: foul smell in the genital area, SSTD4:
excessive genital secretions, SSTD5: swelling of lymphnodes in the
genital area, SSTD6: itching in the genital area, SSTD7: burning pain
onmicturation, SSTD8: pain during intercourse, and SSTD9: genital
ulcers).
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Figure 3: Heat map of Kendall’s tau-𝑏 correlation coefficients
between STIs symptoms and laboratory confirmed STIs (SSTD1:
abdominal pain, SSTD2: abnormal genital discharge, SSTD3: foul
smell in the genital area, SSTD4: excessive genital secretions, SSTD5:
swelling of lymphnodes in the genital area, SSTD6: itching in the
genital area, SSTD7: burning pain on micturation, SSTD8: pain
during intercourse, and SSTD9: genital ulcers).
area (3.2%), swelling of lymphnodes in genital area (1.9%),
and genital ulcers (1.1%). The prevalence of STIs symptoms
among women tested positive for each STI is presented in
Figure 2. Multiple STIs symptoms were reported with almost
all the laboratory-confirmed STIs. Lower abdominal painwas
a common symptom of several infections.
Figure 3 displays a heat map of Kendall’s tau-𝑏 correlation
coefficients used to measure agreements between patient-
reported STIs symptoms and laboratory-confirmed results.
Kendall’s tau-𝑏 value of 1 implies perfect agreement and
values less than 1 imply less than perfect agreement. The
Kendall’s tau-𝑏 coefficients were low (range = −0.04–0.08),
showing no significant associations between each STI symp-
tom and the laboratory-confirmed STI results. When the
symptoms were combined together and summed, the level of
agreement between STIs symptoms and tests remained low
(Kendall’s tau-𝑏 = 0.07, 95% CI: 0.02–0.12).
Figure 4 displays the sensitivity (true positive rate) and
specificity (true negative rate) of each STI symptom, where
sensitivity is the ability of an STI symptom to correctly iden-
tify women who have laboratory-confirmed STIs and speci-
ficity is the ability of an STI symptom to correctly identify
women without laboratory-confirmed STIs. The individual
STI symptoms had very low sensitivity (range = 2%–17%)
and high specificity (range = 85%–99%). The less sensitive
STI symptoms identified individuals as being disease-free
when in fact they were not. Moreover, the more specific
STIs symptoms identified individuals as being disease-free
when they were disease-free. Figure 4 also displays the
sensitivity and specificity of the combined STIs symptoms,
which was defined as a positive response to at least one
of the reported symptoms. The sensitivity and specificity of
the combined STIs symptoms were 0.33 [95% CI: 0.30–0.37]
and 0.73 [95% CI: 0.70–0.77]. The combined STIs symptoms
correctly identified 33 out of 100 women with laboratory-
confirmed STIs and resulted in a 67% false negative rate.
Similarly, the combined STIs symptoms correctly identified
73 out of 100 healthy women and resulted in 27% false
positive rate. Figure 5 displays the area under the receiver-
operating curve (AUROC).TheAUROCmeasures the overall
diagnostic accuracy of the STI symptoms. The closer the
AUROC value is to 1, the better the syndromic diagnosis of
STIs is. The AUROC was 0.53 (95% CI: 046–0.62); that is,
the syndromic approach had a 53% probability of correctly
distinguishing a healthy from an infected woman. The 95%
CI included 50%, indicating that there is no gain in predictive
accuracy by using STIs symptoms. The syndromic approach
showed no advantage over random guess (a random classifier
has an AUROC of 0.5).
4. Discussion
Our study aimed to evaluate the accuracy (performance) of
syndromic management of sexually transmitted infections
(STIs) amongwomen in sub-SaharanAfrica. It included 1,520
women who were enrolled in a community-based survey
from the Moshi Urban District of Northern Tanzania. Half
of the women tested positive for at least one STI, while 30%
reported at least one STIs symptom. The most prevalent
STI among the study participants was HSV-2 (reaching
43%), followed by HIV and Trichomonas infection rates of
11%. The prevalence rates of other STIs were Mycoplasma
Genitalium (3.2%), syphilis (2.5%), chlamydia (1.8%), and
gonorrhea (0.2%). The most prevalent STI symptom was
lower abdominal pain (16%), followed by itching in the
genital area (15%), pain during intercourse (9%), abnormal
genital discharge (6%), and burning or pain on micturation
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Figure 4: Sensitivities and specificities of STIs symptoms together
with their 95% exact confidence intervals (SSTD1: abdominal pain,
SSTD2: abnormal genital discharge, SSTD3: foul smell in the
genital area, SSTD4: excessive genital secretions, SSTD5: swelling
of lymphnodes in the genital area, SSTD6: itching in the genital
area, SSTD7: burning pain on micturation, SSTD8: pain during
intercourse, and SSTD9: genital ulcers).
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Figure 5: The receiver operating characteristics (ROC) curve. The
shaded region represents the area under the ROC curve.
(6%). The prevalence rates of the remaining STIs symptoms
were below 5.0%. We found no significant associations
between patient-reported STIs symptoms and laboratory-
confirmed STIs tests. Furthermore, we found that the individ-
ual STIs symptoms had high specificity and poor sensitivity.
The sensitivity (specificity) of each symptom independently
ranged from 2 to 17% (85–99%). The less sensitive STIs
symptoms identified women as being infection-free when in
fact they were not (high false-negative results). The more
specific STIs symptoms identified women as infection-free
when they were infection-free (low false-positive results).
When the individual STIs were used together, the com-
bined STIs symptoms showed poor sensitivity of 33% and
moderate specificity of 73%. Nearly 67% of the infected
women were missed and almost 27% of the women who
report STIs symptoms were infection-free. The choice of less
sensitive versus more specific tests depends on whether one
wants to exclude a dangerous disease or avoid a dangerous
therapy. A test’s sensitivity (specificity) becomes particularly
important when one is seeking to exclude a dangerous
disease (to confirm a diagnosis that requires dangerous
therapy).
Several previous studies from sub-Saharan African coun-
tries and other parts of the world have reported inconsistent
results on the performance of STIs symptoms. Clark et al.
[18] evaluated the diagnostic performance of self-reported
STIs symptoms among high-risk men and women in Peru.
The authors reported that the STIs symptoms had low
sensitivity and high specificity consistent with our findings.
Low sensitivity and high specificity of self-reported STIs
symptoms were also reported in a Chinese study by Yin
et al. [19]. A study by Mukenge-Tshibaka et al. [13] among
female sex workers in Benin reported poor sensitivity of
the STIs symptoms. Studies in Egypt and India [20, 21]
among women attending antenatal, family planning, and
peripheral government clinics reported high sensitivity and
low specificity of STIs symptoms. In a study conducted
in South Africa among women attending STD clinic, the
sensitivity of STIs symptoms varied greatly, ranging from 0%
to 88%, in detecting different infections [14].
Our study has several strengths compared to previous
studies. It is a large population-based study, enhancing its
generalizability. Most studies on the association between
STIs symptoms and tests have been carried out in particular
groups that are not representative of the overall population,
such as STD or antenatal clinic attendees, or sex workers
[13, 14, 20–22]. However, this study also had some limitations
that may have influenced our findings. First, only women
who agreed to be tested for STIs were included in the
analysis, thereby ignoring the possible systematic differences
between women who consented to be tested for STIs and
those who did not. Analysis of the complete cases can be
biased if there was a systematic difference between cases with
observed data and those with unobserved data. For example,
if women without or with fewer STIs symptoms consented to
be tested, this might have led to an underestimation of the
true association between STIs symptoms and tests. Second,
some of the reported symptoms could have been caused by
infections notmeasured in the study.Thismight have also led
to an underestimation of the true association between STIs
symptoms and tests. Third, the accuracy of the information
given may be affected by the sensitive nature of information
regarding symptoms of STIs. Thus, the self-reported STIs
symptoms might have introduced social desirability and
recall biases and were likely to be underreported.
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The syndromic diagnosis of STIs is often used in resource-
poor settings where laboratory diagnosis is limited. It is
simple, cost effective, and capable of yielding rapid diagnosis
for immediate treatment. However, it should be validated
using population-based data and periodically evaluated.
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